InsidersTradesSigma
Browse the full record of transactions filed by Peter Ostler, Président du Conseil. Insider active across 6 companies, notably Alligator Bioscience AB. Cumulatively, 7 reports have been logged. Activity tracked since 19 May 2025. The latest transaction was filed on 18 December 2025 (Purchase). Regulator: FIN-FSA. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Peter Ostler is the Chairman of Alligator Bioscience AB. In this role, he oversees the activities of the board of directors and contributes to the strategic direction of the company. Alligator Bioscience AB is a Swedish biopharmaceutical company specializing in the development of cancer treatments. Peter Ostler plays a key role in the governance and development of the company.